Enantioselective synthesis and pharmacological evaluation of a new type of verapamil analog with hypotensive and calcium antagonist activities.
- 1 January 1999
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 16 (2) , 281-287
- https://doi.org/10.1023/a:1018888711071
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Study of the in vivo and in vitro cardiovascular effects of a hydralazine‐like vasodilator agent (HPS‐10) in normotensive ratsBritish Journal of Pharmacology, 1997
- Regulation of cytosolic calcium levels in vascular smooth musclePharmacology & Therapeutics, 1996
- Do the K+ channel openers relax smooth muscle by opening K+ channels?Trends in Pharmacological Sciences, 1993
- Effect of urethane on hydralazine-induced tachycardia in ratsGeneral Pharmacology: The Vascular System, 1992
- Role of the endothelial system in BAY K 8644 enantiomer and nifedipine vasomodulator action in rat aortaEuropean Journal of Pharmacology, 1992
- ChemInform Abstract: A Search for Calcium-Channel Activators in the Verapamil Series.ChemInform, 1989
- A comparison of the effects of the calcium entry blockers, verapamil, diltiazem and flunarizine against contractions of the rat isolated aorta and portal veinBritish Journal of Pharmacology, 1988
- Interaction between calcium and slow channel blocking drugs on atrial rate.1983
- Exaggerated Hypotensive Responses to Calcium Antagonists in Spontaneously Hypertensive RatsClinical and Experimental Hypertension. Part A: Theory and Practice, 1983
- [(N-methyl-N-homoveratryl)-gamma-aminopropyl]-3,4-dimethoxyphenyl-acetonitrile, a substance with coronary vasodilating properties].1962